As of 2:31 PM on the 10th, Celltrion is trading at 317,000 KRW, up 0.79% from the previous day. The trading volume is 1,082,529 shares, which is 128.95% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On August 10th, Shin Jae-hoon, a researcher at Hanwha Investment & Securities, stated, "Celltrion has announced outstanding performance. We maintain a target price of 450,000 KRW and a top pick rating within the industry," setting Celltrion's target price at 450,000 KRW.

Over the past five days, individual investors have net sold 97,332 shares of Celltrion, while foreign investors and institutions have net bought 52,548 shares and 33,313 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing